<DOC>
	<DOCNO>NCT00071344</DOCNO>
	<brief_summary>This study examine patient non-small cell lung cancer metastasis , , distant spreading tumor brain , compare patient without brain metastasis . The molecular genetic event permit tumor metastasis well understood . There intense investigation go process tumor cell escape primary local tumor , spread distant place body , find create condition promote growth tissue . Metastasis tumor lung cancer brain common problem . Tumor cell analyze use microarrays . A microarray tool analyze gene expression , consist small membrane glass slide contain sample many gene arrange regular pattern . The goal identify potential molecular signature . It hop discovery patient likely others develop brain metastasis , major negative effect quality life survival . Patients 18 year age know evidence radiology non-small cell lung cancer metastatic brain , either squamous cell adenocarcinoma tumor , removal brain tumor diagnosis treatment may eligible study . Participants undergo follow procedure test : - Craniotomy , , surgical opening skull , removal brain tumor . - Blood specimen take central vein artery operation , throughout need , several day afterward , measure blood chemistry , blood count , forth . - Physical examination image central nervous system surgery . - Urine serum , , pregnancy test woman childbearing potential . Patients also undergo blood test 3-month interval surgery 5 year . The purpose determine tumor cell blood , may explain reach brain .</brief_summary>
	<brief_title>Analysis Brain Metastasis Patients With Lung Cancer</brief_title>
	<detailed_description>Introduction : The molecular genetic event permit tumor metastasis well understood . The process whereby tumor cell escape primary , local tumor , spread distant sit body find create condition conducive growth disparate tissue remain area intense investigation . Metastasis epithelial tumor , lung cancer , brain common problem , significant consequence respect neurological dysfunction shorten survival . Objective : To study two subset patient non small cell lung cancer ( NSCLC ) metastatic brain , identify gene protein facilitate metastasis . Study Population : 78 patient NSCLC ( n=39 squamous cell ( SQ ) , n=39 adenocarcinoma ( AC ) tumor ) metastatic brain compare publish microarray study non-metastatic NSCLC patient tumor type well one another help explain differential trend toward metastasis patient NSCLC others , well differential trend brain metastasis AC subtype . Anticipated Risks Benefits : Less minimal risk patient sample tissue already remove brain part medically-necessary surgery sample blood . No direct benefit patient expect . Outcome Estimate Potential Meaning Field : That detail investigation gene protein express differentially non-metastatic metastatic NSCLCs , well SQ AC subtypes identify new previously-unsuspected target new therapy either prevent development brain metastasis treat brain metastasis effectively .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . A patient know radiographic evidence NSCLC neoplasm metastatic brain , either SQ AC . 2 . Medicallyindicated ( diagnostic and/or therapeutic ) brain tumor resection . 3 . Informed consent female patient , age 18 older . In general , patient le 18 year age rarely NSCLC metastatic brain . 1 . Inability provide inform consent prior surgery . 2 . Medical condition correct prior surgery would standard contraindication craniotomy ( brain tumor patient ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2004</verification_date>
	<keyword>Microarray</keyword>
	<keyword>Genomics</keyword>
	<keyword>Trastuzumab</keyword>
	<keyword>Carcinoma</keyword>
	<keyword>Non-Small Cell Lung Cancer</keyword>
	<keyword>Metastatic Brain Tumor</keyword>
	<keyword>Brain</keyword>
	<keyword>Microarrays</keyword>
	<keyword>Microdissection</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>NSCLC</keyword>
</DOC>